Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lourdes Millán-Pérez Peña"'
Autor:
Dalia González-Esparragoza, Alan Carrasco-Carballo, Nora H. Rosas-Murrieta, Lourdes Millán-Pérez Peña, Felix Luna, Irma Herrera-Camacho
Publikováno v:
Current Issues in Molecular Biology, Vol 46, Iss 5, Pp 4609-4629 (2024)
Ermp1 is a putative metalloprotease from Schizosaccharomyces pombe and a member of the Fxna peptidases. Although their function is unknown, orthologous proteins from rats and humans have been associated with the maturation of ovarian follicles and in
Externí odkaz:
https://doaj.org/article/e6df0069ed9747269a730ef743ed2e25
Autor:
Lilian Karem Flores-Mendoza, Tania Estrada-Jiménez, Virginia Sedeño-Monge, Margarita Moreno, María del Consuelo Manjarrez, Guadalupe González-Ochoa, Lourdes Millán-Pérez Peña, Julio Reyes-Leyva
Publikováno v:
Mediators of Inflammation, Vol 2017 (2017)
Background. Cytokines play important roles in the physiopathology of dengue infection; therefore, the suppressors of cytokine signaling (socs) that control the type and timing of cytokine functions could be involved in the origin of immune alteration
Externí odkaz:
https://doaj.org/article/429a2f7cbf424769ab4af3faee7688e3
Autor:
Alan Rodríguez-Enríquez, Irma Herrera-Camacho, Lourdes Millán-Pérez-Peña, Julio Reyes-Leyva, Gerardo Santos-López, José Francisco Rivera-Benítez, Nora Hilda Rosas-Murrieta
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
The membrane protein M of the Porcine Epidemic Diarrhea Virus (PEDV) is the most abundant component of the viral envelope. The M protein plays a central role in the morphogenesis and assembly of the virus through protein interactions of the M-M, M-Sp
Externí odkaz:
https://doaj.org/article/7ca68167b50743a7b35bc2e28dc8274f
Autor:
Karen Andrea Larrauri-Rodríguez, Bertha Alicia Leon-Chavez, Verónica Vallejo-Ruiz, Lourdes Millán-Perez Peña, Paola Maycotte
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
IntroductionAmong the types of cancer affecting women, cervical cancer (CC) is a public health problem with high global incidence and mortality rates. It is currently classified into three main histological types: squamous cell carcinoma (SCC), adeno
Externí odkaz:
https://doaj.org/article/d5afd0f660e14609be1a3f4c594c6246
Autor:
Eduardo Monjaraz, Eleazar Lara-Padilla, Maricruz Anaya-Ruiz, Cindy Bandala, Irma Herrera-Camacho, Lourdes Millán-Pérez Peña, Amira Flores, Jorge Cebada, Nora Hilda Rosas-Murrieta, Martin Perez-Santos
Publikováno v:
Expert Opinion on Therapeutic Patents. 31:81-90
OX40 is an immune checkpoint in cancer and its presence in cancer is a good prognosis, making it a highly relevant target for the development of new immunotherapies.The patent literature reveals vital information on new trends in cancer therapies. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b0b3bf5c60dc843e1f2def17c41123
https://doi.org/10.1080/13543776.2021.1825688
https://doi.org/10.1080/13543776.2021.1825688
Autor:
Irma Herrera-Camacho, Martin Perez-Santos, Lourdes Millán-Pérez Peña, Nora Hilda Rosas-Murrieta, Maricruz Anaya-Ruiz
Publikováno v:
Expert Opinion on Therapeutic Patents. 30:83-86
Introduction: TIGIT is an inhibitory receptor expressed by lymphocytes that suppresses the immune response against tumor cells. There is a great need to discover and develop new therapies focused on inhibiting the action of TIGIT and consequently imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a4f4c0523beaa3b428a67739d3ab5f
https://doi.org/10.1080/13543776.2020.1709445
https://doi.org/10.1080/13543776.2020.1709445
Autor:
Martin Perez-Santos, Maricruz Anaya-Ruiz, Irma Herrera-Camacho, Cindy Bandala, Lourdes Millán-Pérez Peña, Gerardo Landeta
Publikováno v:
Expert Opinion on Therapeutic Patents. 29:587-593
Introduction: TIM3 and PD-1 are checkpoint inhibitors in cancer that coordinate the downregulation of the proliferation of antigen-specific lymphocytes. There is a great need to discover and develop new therapies focused on inhibiting the action of T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f69f556c4601873eb6dd4f4b86c763c
https://doi.org/10.1080/13543776.2019.1637422
https://doi.org/10.1080/13543776.2019.1637422
Autor:
Ana-Karina Aguilar-Peralta, Alejandro Gonzalez-Vazquez, Daniel Martinez-Fong, Eduardo Brambila, Juan-Antonio Gonzalez-Barrios, Lourdes Millán-Pérez Peña, Bertha Alicia León-Chávez, Victorino Alatriste, Samuel Treviño, Victor-Manuel Blanco-Alvarez, Constantino Tomas-Sanchez, Guadalupe Soto-Rodriguez
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2021 (2021)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Oxygen deprivation in newborns leads to hypoxic-ischemic encephalopathy, whose hallmarks are oxidative/nitrosative stress, energetic metabolism alterations, nutrient deficiency, and motor behavior disability. Zinc and taurine are known to protect aga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffed57dd74cd8c15d108d19144d2a59f
https://doaj.org/article/e6e7e3179abe4fe8b313f222cd6ee219
https://doaj.org/article/e6e7e3179abe4fe8b313f222cd6ee219
Autor:
Cindy Bandala, Lourdes Millán-Pérez Peña, Maricruz Anaya-Ruiz, Perez-Santos Martin, Irma Herrera-Camacho
Publikováno v:
Expert opinion on therapeutic patents. 30(5)
Introduction: GITR is a receptor that increases the activation of T lymphocytes against tumor cells. There is a great need to discover and develop new therapies focused on activating GITR to increase the immune response in various types of cancer. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecb36adb3abb45db8cfd6ad61f410b18
https://pubmed.ncbi.nlm.nih.gov/32106724
https://pubmed.ncbi.nlm.nih.gov/32106724
Autor:
Lourdes Millán-Pérez Peña, Irma Herrera-Camacho, Nora Hilda Rosas-Murrieta, Martin Perez-Santos, Maricruz Anaya-Ruiz
Publikováno v:
Expert opinion on therapeutic patents. 29(12)
Introduction: OX40 is a potent costimulatory receptor of the immune response in various types of cancer and has been used as a target for the generation of agonists of its function. Authors of WO2018202649 patent propose a method to eradicate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e28a4e66d0b0ade252b3200ff607924
https://pubmed.ncbi.nlm.nih.gov/31627712
https://pubmed.ncbi.nlm.nih.gov/31627712